Bristol-Myers Squibb Company beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $1.59 | $2.04 | +28.3% | Beat |
| Q12026 FY2026 | $1.44 | $1.58 | +9.7% | Beat |
| Q42025 FY2025 | $1.15 | $1.26 | +9.6% | Beat |
Back to BMY overview · BMY holders · BMY KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.